From AstraZeneca announcing that it’s blood cancer drug Calquence is not effective for patients with COVID-19 to a street artist using a lab pipette to create a painting representing cancer out of 50,000 dots of paint, here’s what’s happening in the cancer landscape this week.
Finding cancer may be easier now, as blood tests are being developed to diagnose patients with asymptomatic cancer.
Findings from this analysis determined that diet may not affect survival, which may lead to a stronger focus on exercise at the start of first-line treatment for metastatic disease.
In this episode of the “CURE Talks Cancer” podcast, we spoke with a couple that has been married for 41 years about their journey as patient and caregiver during two bouts of triple-negative breast cancer. The couple, Janice and Rex Cowden, also give others facing similar situations advice on how to persevere together.
Paying attention to the updated nutritional labels on food can help Americans stay within dietary guidelines and prevent illness, including cancer.
One man discovered that his experience with testicular cancer inspired jokes he could share with others.
CAR-T cell therapy is a relatively new treatment option for patients with blood cancers, but it’s one showing promise across the landscape. Here’s what you need to know.
Businesses are reopening offices, leaving unanswered questions for employees who have cancer or take care of someone who does.
Dr. Dan Tran discusses his stage 4 lung cancer diagnosis at age 30, and how he has managed the shift from doctor to the patient with cancer.
On behalf of the National Pancreas Foundation, Dr. Diane Simeone offers insight into early detection options for those at increased risk of pancreatic cancer, including surveillance and screening.
Doctors told Maryland Governor Larry Hogan to go home and rest after undergoing cancer surgery. But he had other plans: sharing his health issues.
A randomized, controlled trial comparing olanzapine with a standard antiemetic regimen resulted in more patients achieving no vomiting and no rescue medication during the acute, delayed and overall periods.
These findings, based on a 20-year analysis, may show the benefit with weight loss surgery to reduce the effects of chronic inflammation associated with diabetes and obesity.
The FDA approved this liquid biopsy to check blood for prostate-tumor DNA that indicates the presence of genetic mutations or rearrangements. The test was also recently approved for use in patients with ovarian, non-small cell lung or breast tumors.
Financial hardship, particularly related to debt and psychological distress, can affect young female cancer survivors who may have to reduce hours or stop work completely.
Oncology nursing can be an art form all to itself when nurses put their own spin on how to approach patients with cancer.
Legendary “Jeopardy!” host Alex Trebek died on Sunday after receiving a pancreatic cancer diagnosis in March 2019. He was 80.
Oncology nurses provide a knowledgeable, reflective and thoughtful position for patients with cancer.
President-elect Joseph R. Biden Jr. has won the 2020 presidential election, which could impact the future of cancer care – in particular with the Affordable Care Act and the Cancer Moonshot Initiative.
Working in the pediatric oncology field requires a special touch, one full of compassion and selflessness. Traits that oncology nurses have in spades.
Patients with resected, high-risk, stage 3 melanoma who were randomized to receive Keytruda (pembrolizumab) achieved a three-year recurrence-free survival rate of 63.7% compared to 44.1% in patients randomized to placebo.
In an interview with CURE®, Dr. Phillip J. Koo defines what theranostics is, discusses the treatment’s potential and answers questions patients may have regarding its safety.
From a Canadian man shaving his moustache for the first time in nearly 50 years to participate in Movember to HGTV’s “Flip or Flop” host Tarek El Moussa discussing his journey with testicular and thyroid cancer, here’s what’s happening in the cancer landscape this week.
In a candid announcement on Friday, November 6th, famed Today Show host Al Roker announced his recent prostate cancer diagnosis and prognosis.
Outcomes for patients with Hodgkin lymphoma continue to improve, thanks to new drugs, according to Dr. Pamela Allen.
New treatment options are outperforming the “old-fashioned” chemotherapy regimens for patients with CLL and SLL, according to Dr. Locke J. Bryan.
The FDA is reviewing what could become the first-ever medication specifically for kidney cancer associated with von Hippel-Lindau disease.
Three targeted drugs have recently been approved to treat diffuse large B-cell lymphoma, broadening the treatment options for patients with this aggressive blood cancer, according to Dr. Germame Ajebo.
This benefit observed with Venclexta (venetoclax) plus Rituxan (rituximab) for patients with CLL was particularly strong in patients with undetectable minimal residual disease, which may predict clinical outcome after chemoimmunotherapy.
The RACE for Children Act will create more clinical trial options for young patients with cancer and, ultimately, more pediatric oncology drugs.
